newsfilter
← Latest News
GlobeNewswire·

Nasdaq Grants Adamis Pharmaceuticals' Request for Extension to Comply with Continued Listing Requirements

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various